Your browser doesn't support javascript.
loading
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
Reid, Michael; Agbassi, Yvan Jean Patrick; Arinaminpathy, Nimalan; Bercasio, Alyssa; Bhargava, Anurag; Bhargava, Madhavi; Bloom, Amy; Cattamanchi, Adithya; Chaisson, Richard; Chin, Daniel; Churchyard, Gavin; Cox, Helen; Denkinger, Claudia M; Ditiu, Lucica; Dowdy, David; Dybul, Mark; Fauci, Anthony; Fedaku, Endalkachew; Gidado, Mustapha; Harrington, Mark; Hauser, Janika; Heitkamp, Petra; Herbert, Nick; Herna Sari, Ani; Hopewell, Philip; Kendall, Emily; Khan, Aamir; Kim, Andrew; Koek, Irene; Kondratyuk, Sergiy; Krishnan, Nalini; Ku, Chu-Chang; Lessem, Erica; McConnell, Erin V; Nahid, Payam; Oliver, Matt; Pai, Madhukar; Raviglione, Mario; Ryckman, Theresa; Schäferhoff, Marco; Silva, Sachin; Small, Peter; Stallworthy, Guy; Temesgen, Zelalem; van Weezenbeek, Kitty; Vassall, Anna; Velásquez, Gustavo E; Venkatesan, Nandita; Yamey, Gavin; Zimmerman, Armand.
Afiliación
  • Reid M; University of California San Francisco Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: Michael.reid@ucsf.edu.
  • Agbassi YJP; Global TB Community Advisory Board, Abidjan, Côte d'Ivoire, Yenepoya Medical College, Mangalore, India.
  • Arinaminpathy N; School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
  • Bercasio A; University of California San Francisco Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
  • Bhargava A; Department of General Medicine, Yenepoya Medical College, Mangalore, India.
  • Bhargava M; Department of Community Medicine, Yenepoya Medical College, Mangalore, India.
  • Bloom A; Division of Tuberculosis, Bureau of Global Health, USAID, Washington, DC, USA.
  • Cattamanchi A; School of Medicine, University of California, Irvine, CA, USA.
  • Chaisson R; Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Chin D; Bill and Melinda Gates Foundation, Seattle, WA, USA.
  • Churchyard G; Aurum Institute, Johannesburg, South Africa.
  • Cox H; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Denkinger CM; Heidelberg University Hospital, German Center of Infection Research, Heidelberg, Germany.
  • Ditiu L; Stop TB Partnership, Geneva, Switzerland.
  • Dowdy D; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Dybul M; Department of Medicine, Center for Global Health Practice and Impact, Georgetown University, Washington, DC, USA.
  • Fauci A; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Fedaku E; Volunteer Health Services, Addis Ababa, Ethiopia.
  • Gidado M; KNCV Tuberculosis Foundation, The Haag, Netherlands.
  • Harrington M; Treatment Action Group, New York, NY, USA.
  • Hauser J; Campaigns in Global Health, Cambridge, UK.
  • Heitkamp P; McGill International TB Centre, McGill University, Montreal, QC, Canada.
  • Herbert N; Global TB Caucus, Houses of Parliament, London, UK.
  • Herna Sari A; Global TB Community Advisory Board, Surabaya, Indonesia.
  • Hopewell P; University of California San Francisco Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
  • Kendall E; Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Khan A; Interactive Research & Development, Karachi, Pakistan.
  • Kim A; University of California San Francisco Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
  • Koek I; Save the Children, Fairfield, CT, USA.
  • Kondratyuk S; Global TB Community Advisory Board, Kyiv, Ukraine.
  • Krishnan N; Resource Group for Education and Advocacy for Community Health (REACH), Chennai, India.
  • Ku CC; School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
  • Lessem E; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • McConnell EV; Treatment Action Group, New York, NY, USA.
  • Nahid P; University of California San Francisco Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
  • Oliver M; Campaigns in Global Health, Cambridge, UK.
  • Pai M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Centre, McGill University, Montreal, QC, Canada.
  • Raviglione M; Centre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy.
  • Ryckman T; Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Schäferhoff M; Open Consultants, Berlin, Germany.
  • Silva S; Harvard TH Chan School of Public Health, Harvard University, Cambridge, MA, USA.
  • Small P; Hyfe AI, Wilmington, DE, USA.
  • Stallworthy G; Bill and Melinda Gates Foundation, Seattle, WA, USA.
  • Temesgen Z; Mayo Clinic, Rochester, MN, USA.
  • van Weezenbeek K; WHO, Geneva, Switzerland.
  • Vassall A; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
  • Velásquez GE; University of California San Francisco Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
  • Venkatesan N; Blavatnik School of Government, University of Oxford, Oxford, UK.
  • Yamey G; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA.
  • Zimmerman A; Open Consultants, Berlin, Germany.
Lancet ; 402(10411): 1473-1498, 2023 10 21.
Article en En | MEDLINE | ID: mdl-37716363

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Límite: Humans Idioma: En Revista: Lancet Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Límite: Humans Idioma: En Revista: Lancet Año: 2023 Tipo del documento: Article